baber/WOPTO huggingface dataset:
Patent CA-2597836-A1 (CA)
Inventor: BLATTMAN KIRK
IPC: H04N7/173
Filed: 2006-02-23
Abstract: In a digital video network that is capable of distributing digital video content to a client via multicasting and unicasting, servicing a channel change request from a client involves switching from providing the digital video content to the client via multicasting to providing the digital video content to the client via unicasting and continuing to provide digital video content to the client via unicasting until a pre- established condition is met. Continuing to provide digital video content to the client via unicasting until a pre-established condition is met allows the network to opportunistically switch the client from unicasting back to multicasting.
Patent CA-2599871-A1 (CA)
Title: Method for differentiation of stem cells
Inventor: DE SOUSA PAUL A
IPC: C12N5/0775
Filed: 2006-03-03
Abstract: A method for the differentiation of mammalian pluripotent stem (PS) cells into a mortal multi-lineage progenitor cell population is provided which comprises culturing the pluripotent stem cells in the presence of Hyaluronan (HA). The mortal multi-lineage progenitor cell population may be a population of mesenchymal stem cells. The mortal multi-lineage progenitor cell population may form cells of the mesodermal lineage, suitably osteoblasts. Alternatively, the mortal multi-lineage progenitor cell population may form cells of the endodermal lineage or of the ectodermal lineage, which may be neuronal progenitors.
Patent CA-2602574-A1 (CA)
Title: Cytoskeletal active compounds, composition and use
Inventor: WATSON PAUL S
IPC: C07D498/08
Filed: 2006-03-23
Abstract: The present invention is directed to synthetic cytoskeletal active compounds that are related to natural Latrunculin A or Latrunculin B. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptable carrier. The invention is additionally directed to a method of preventing or treating diseases or conditions associated with actin polymerization. In one embodiment of the invention, the method treats increased intraocular pressure, such as primary open-angle glaucoma. The method comprises administering to a subject a therapeutically effective amount of a cytoskeletal active compound of Formula I or II, wherein said amount is effective to influence the cytoskeleton, for example by inhibiting actin polymerization.
Patent CA-2604203-A1 (CA)
Inventor: HANNUKSELA MISKA
IPC: H04N7/26
Filed: 2006-04-10
Abstract: A method and device for encoding, decoding, storage and transmission of a scalable data stream to include layers having different coding properties. The method includes: producing one or more layers of the scalable data stream, wherein the coding properties include at least one of the following: Fine granularity scalability information; Region-of-interest scalability information; Sub-sample scalable layer information; Decoding dependency information; and Initial parameter sets, and signaling the layers with the characterized coding property such that they are readable by a decoder without the need to decode the entire layers. Also, a method of encoding, decoding, storage, and transmission of a scalable bit stream, wherein at least two scalability layers are present and each layer is characterized by a set of at least one property, such as Fine granularity scalability information; Region-of-interest scalability information; Sub-sample scalable layer information;  Decoding dependency information; and Initial parameter sets, that may be different from that of the entire stream, and wherein the set of at least one property is signaled for at least one layer that is different from the entire stream, wherein signaling of the set of at least one property may be in the scalable bit stream, in a file format container containing the scalable bit stream, or in a transmission or control protocol for transmission or control of at least one layer of the scalable bit stream.
Patent CA-2604748-A1 (CA)
Inventor: NOKKALA JORMA
IPC: A01G23/091
Filed: 2007-09-28
Abstract: The invention relates to a working machine system, including equipment for felling a tree (1, 18) to be processed, equipment (14) for delimbing branches (20) of the tree (1, 18), and equipment for cutting the tree trunk to a desired length. In addition, the working machine system includes equipment for producing chopped wood, said equipment including means (9, 9') for riving a trunk of the felled tree (18) in a longitudinal direction of the tree, as well as chopping means (11) for cutting the tree to a length matching that of chopped wood.
Patent CA-2607632-A1 (CA)
Title: Toner and developer, toner container, process cartridge, image forming apparatus, and image forming method using the same
Inventor: WAKAMATSU SHINICHI
IPC: G03G15/20
Filed: 2006-05-10
Abstract: It is an object of the present invention to provide a toner containing an ethyl acetate-soluble polyester component and an ethyl acetate-insoluble polyester component, wherein the toner is granulated in an aqueous medium, the ethyl acetate-insoluble polyester component is obtained by elongating and/or cross-linking a modified polyester resin during granulating and/or after granulating, the modified polyester resin is produced by condensation polymerization of an acid component and at least one type of diol compound selected from aliphatic diol and alicyclic diol in the presence of a catalyst, and the mass average molecular weight of the modified polyester resin is 10,000 to 100,000.
Patent CA-2612106-A1 (CA)
Title: Fungicide composition comprising a phosphorous acid derivative, a mandelamide type compound and a further fungicide compound
Inventor: LATORSE MARIE-PASCALE
IPC: A01N37/18
Filed: 2006-06-20
Abstract: The invention relates to active compound combinations, in particular within a fungicide composition, which comprise a phosphorous acid derivative (phosphonate or phosphite derivative), a compound of the mandelamide type like mandipropamid and a further fungicide compound. Such combinations are very highly suitable for controlling phytopathogenic fungi.
Patent CA-2615134-A1 (CA)
Title: Light emitting diode comprising semiconductor nanocrystal complexes
Inventor: CHEON KWANG-OHK
IPC: H01L33/64
Filed: 2006-07-13
Abstract: A light emitting diode (LED) formed by depositing an LED chip and coupling a stability layer to the LED chip. Semiconductor nanocrystals are placed in a first matrix material to form a nanocrystal complex layer. The nanocrystal complex layer is deposited on top of the stability layer. A thickness of the stability layer is chosen to maximizes a power of a light output by the nanocrystal complex layer. The matrix material and the stability layer can be of the same type of material. Additional layers of matrix material can be deposited on top of the nanocrystal complex layer. These additional layers can comprise matrix material only or can comprise matrix material and semiconductor nanocrystals to form another nanocrystal complex layer.
Patent CA-2615814-A1 (CA)
Title: Multiple fluid dispenser
Inventor: OBRECHT ANTON
IPC: B01F13/10
Filed: 2006-07-17
Abstract: An improved multi fluid dispenser for simultaneous dispensing of a plurality of fluids is shown and described. The dispenser (40) includes a controller (66) that is linked to a coordinator board (65). The controller has a memory with a plurality of recipes stored in the memory. A coordinator board is linked to a first module (45). The first module may include one or two pumps (74), each connected to a fluid reservoir (69). The module is then linked in series to a plurality of other modules as well as a manifold module (46). Each module includes a module board (67) for controlling the pump or pumps of that module. The controller, coordinator board and module boards are all programmed for the simultaneous or sequential pumping of multiple fluids from the reservoirs through outlet nozzles of the manifold in accordance with a recipe selected by the user and retrieved from the memory of the controller.
Patent CA-2615995-A1 (CA)
Inventor: NAIR ANISH
IPC: G09B7/00
Filed: 2006-07-19
Abstract: A system and method for spoken language proficiency assessment by a computer is described. A user provides a spoken response to a constructed response question. A speech recognition system processes the spoken response into a sequence of linguistic units. At training time, features matching a linguistic template are extracted by identifying matches between a training sequence of linguistic units and pre-selected templates. Additionally, a generalized count of the extracted features is computed. At runtime, linguistic features are detected by comparing a runtime sequence of linguistic units to the feature set extracted at training time. This comparison results in a generalized count of linguistic features. The generalized count is then used to compute a score.
Patent CA-2616071-A1 (CA)
Title: Dermocosmetic preparations
Inventor: WUENSCH THOMAS
IPC: A61Q5/00
Filed: 2006-07-14
Abstract: The present invention relates to dermocosmetic compositions comprising a compound containing the structural element of the formula (1), in which the radical Z has the following definition: H, C1-C22 alkyl group, C6-C10 aryl group, C1-C22 alkoxy group or a C6-C10-O-aryl group substituted by a C1-C22 alkyl or C1-C22 alkoxy group, and the radicals R1 to R6 have independently of one another the following definition: H, C1-C22 aIkyl group, C6-C10 aryl group, O, OH, C1-C22 alkoxy group or a C6-C10-O-aryl group substituted by C1-C22 alkyl or C1-C22 alkoxy group, it being possible for R5 and R6 to be bridged in such a way as to form a five- to eight-membered ring, which in the case of a five-membered ring may be part of an oligomer through covalent bonds at positions 3 and 4. The invention further relates to the use of the specified compounds in dermocosmetic preparations and to the use of the dermocosmetics of the invention for reducing damage to skin or hair that is brought about by free radicals. A further subject of the invention relates to the use of the compounds of the invention for raising the shelf life of dermocosmetic preparations.
Patent CA-2616633-A1 (CA)
Inventor: PATEL YOGESH P
IPC: G21F5/015
Filed: 2006-07-26
Abstract: The invention relates to the handling of radioactive material. For instance, a radiation shield of the invention may include a body having a cavity therein for receiving radioactive material. An opening to the cavity may be defined in the body. A base may be releasably attachable to the body (generally toward the opening) to at least partially enclose the radioactive material in the cavity. In the case that the radiation shield includes a plurality of interchangeable bases, one of the bases may have at least one of a shorter length and a lighter weight than another of the bases. The base(s) may be designed to enclose more than one size and/or shape of container in the cavity. The base(s) may include a hand grip to facilitate manual gripping of the radiation shield. The base(s) may include a guard to reduce exposure to radiation from manual handling of the radiation shield.
Patent CA-2618470-A1 (CA)
Inventor: CARLETON ANTHONY SMITH
IPC: H04L12/66
Filed: 2006-05-18
Abstract: A method for use in diverse networks that authenticates inter-network resource requests. A router in a first network receives a request for a resource from a second network. The router sends a query to an element in the second network to determine whether the request actually originated there. If the request did originate from the second network, the request is processed according to the procedure for the requested resource. If the request did not originate from the second network, then the first network terminates the request. Thus, no network resources are consumed unnecessarily by accidental or malicious requests.
Patent CA-2619763-A1 (CA)
Title: Fas binding antibodies
Inventor: ALDRICH JENNIFER L
IPC: G01N33/574
Filed: 2006-08-17
Abstract: The disclosed invention relates to monoclonal antibodies (MAbs) which recognize human fatty acid synthase (hFAS) and are distinct from previously known anti-hFAS antibodies. Compositions, devices and kits comprising the MAbs are provided along with methods of using the MAbs in a variety of applications.
Patent CA-2624418-A1 (CA)
Inventor: ROBIN HOWARD
IPC: C07K14/47
Filed: 2006-10-03
Abstract: The present invention relates to compounds, compositions, and methods for the study, diagnosis, and treatment of traits, diseases and conditions that respond to the modulation of influenza virus gene expression and/or activity.  The present invention is also directed to compounds, compositions, and methods relating to traits, diseases and conditions that respond to the modulation of expression and/or activity of genes involved in influenza virus gene expression pathways or other cellular processes that mediate the maintenance or development of such traits, diseases and conditions. Specifically, the invention relates to double stranded nucleic acid molecules including small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA(dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules capable of mediating RNA interference (RNAi) against influenza virus gene expression, including cocktails of such small nucleic acid molecules and lipid nanoparticle (LNP) formulations of such small nucleic acid molecules. The present invention also relates to small nucleic acid molecules, such as siNA, siRNA, and others that can inhibit the function of endogenous viral and/or host RNA molecules, such as endogenous viral and/or host micro-RNA (miRNA) (e.g, miRNA inhibitors) or endogenous short interfering RNA (siRNA), (e.g., siRNA inhibitors) or that can inhibit the function of RISC (e.g., RISC inhibitors), to modulate influenza virus and/or host gene expression by interfering with the regulatory function of such endogenous RNAs or proteins associated with such endogenous RNAs (e.g., RISC), including cocktails of such small nucleic acid molecules and lipid nanoparticle (LNP) formulations of such small nucleic acid molecules. Such small nucleic acid molecules and are useful, for example, in providing compositions to prevent, inhibit, or reduce influenza virus infection, acute laryngotracheobronchitis, pneumonia, secondary bacterial infection, myositis, encephalopathy, Reye's syndrome, Guillain-Barre syndrome, and/or cardiac failure and/or other disease states, conditions, or complications associated with influenza virus infection in a subject or organism.
Patent CA-2625374-A1 (CA)
Inventor: YE IVAN
IPC: B05B1/30
Filed: 2006-10-13
Abstract: A spraying device for spraying fragrance, pest control composition and/or a sanitising composition held within a pressurised container, the spraying device comprising a container receiving section (13) and a switching section (10) wherein the switching section (10) incorporates a solenoid switch.
Patent CA-2627696-A1 (CA)
Inventor: BOCK THOMAS-MATHIAS
IPC: B64D11/00
Filed: 2006-10-24
Abstract: The invention relates to a bin for luggage (2), comprising a compartment having a lower external face (8), an upper face (12), an open face for accessing the compartment and a base (10). The inventive bin is mounted such that it can pivot about a pivot axis (4) between an open position in which the open face of the compartment can be accessed and in which the rear part (26) of the lower external face (8) is concealed and a closed position in which the open face of the compartment is retracted and in which the rear part (26) of the lower external face (8) is visible. The aforementioned rear part (26) takes the form of a cylinder having generatrices (34, 36) that are essentially parallel to the pivot axis (4) of the bin. Moreover, the distance (R1, R2) from the pivot axis (4) to the generatrices (R1, R2) increases from the base (10) of the compartment towards the open face of same.
Patent CA-2628476-A1 (CA)
Inventor: TOMIYAMA YOSHITAKA
IPC: A61K31/4045
Filed: 2006-11-22
Abstract: The object is to provide a pharmaceutical useful for the remission of a pain caused by ureterolithiasis, the acceleration of removal of a calculus present in the ureter from the body or the like. Disclosed is a therapeutic pharmaceutical for ureterolithiasis, which has a potent inhibitory effect on the contraction of the ureter and comprises an indoline derivative represented by the general formula (I) or a salt thereof as an active ingredient: (I) wherein R represents an aliphatic acyl which may have a substituent and may have an unsaturated bond, a hydroxyalkyl, an aliphatic acyloxyalkyl, a lower alkyl which may have a lower alkoxy, a carboxy, a lower alkoxycarbonyl, an aryl-substituted lower alkoxycarbonyl, a carbamoyl, a monoalkyl- or dialkyl-substituted carbamoyl or a cyano as a substituent, an aromatic acyl which may have be substituted, a furoyl or a pyridylcarbonyl; R1 represents a cyano or carbamoyl; and R2 represents a lower alkyl which may have a halogen, a cyano or a aryl as a substituent.
Patent CA-2629851-A1 (CA)
Inventor: HAGEDORN ALEXANDER
IPC: B02C4/02
Filed: 2006-12-19
Abstract: Double roller machine comprises a machine table (19) with a reciprocally moving table top (21, 22) underneath a slip-on gear mechanism (15, 16). The slip-on gear mechanism is mounted in an offset-free manner during (dis)assembly on three vertically and horizontally adjustable supports arranged on the table top. After alignment of the slip-on gear mechanism the table top is moved with the slip-on gear mechanism, and the connection (20, 20a) between roller shaft drive pins and the driven side of the gear mechanism is hydraulically loaded during gear assembly and unloaded during gear disassembly. Preferred Features: The table top slides on the machine table on roller conveyors or sliding tracks made e.g. of Teflon chromium sheet.
Patent CA-2630399-A1 (CA)
Inventor: GEE NICHOLAS STEVEN
IPC: A61K47/48
Filed: 2006-12-12
Abstract: A method of reacting a first chemical entity and a second chemical entity to form a conjugate in which the first and second chemical entities are covalently bound with respect to each other, comprises bringing into simultaneous contact the first chemical entity, the second chemical entity and a thiol generator, wherein the thiol generator reacts with the first chemical entity in a thiolation reaction resulting in formation of a free sulfhydryl group on the first chemical entity, and the free sulfhydryl group reacts with the second chemical entity to form the conjugate, and wherein the second chemical entity is polyvalent with respect to its reactivity with sulfhydryl groups. The present invention primarily differs from the prior art in that no separation step is involved between reaction of the thiol generator and first chemical entity and reaction with the second chemical entity. The invention also provides a conjugation kit.
Patent CA-2634377-A1 (CA)
Inventor: VIDALIN OLIVIER
IPC: A61K39/00
Filed: 2006-12-20
Abstract: The present invention relates to methods of eliciting an immune response by use of a prime-boost schedule for delivering a polynucleotide encoding a heterologous non-self antigen. In particu-lar, the invention relates to a prime-boost schedule wherein the prim-ing polynucleotide composition is delivered by an adenoviral vector, and the boosting polynucleotide composition is coated on or incorpo-rated in a particle and is administered by a particle acceleration device.
Patent CA-2635074-A1 (CA)
Inventor: HANANIA RAMZI
IPC: A61M1/12
Filed: 2006-12-04
Abstract: La présente invention concerne des procédés et un appareil pour sélectionner un mode de durée de dégonflement pour un ballon intra-aortique (IAB) en se basant sur une comparaison du temps nécessaire pour dégonfler l~IAB et le temps écoulé entre l'onde ECG R et l'ascendance systolique.
Patent CA-2635248-A1 (CA)
Title: Free-standing anchor truss
Inventor: PEACE ROSS L K
IPC: H02S20/23
Filed: 2008-05-28
Abstract: This free-standing anchor is designed to be un-attached to the surface upon which it is placed, and functions to reliably restrict the motion of an object to which it is connected. The unique shape of this invention is based on efficient truss geometry and modular design. The result is a 'weighted anchor' with reduced manufacturing costs, reduced shipping weight, and a simplified installation process.
Patent CA-2637606-A1 (CA)
Inventor: SHIMP LARRY
IPC: A61F2/28
Filed: 2007-01-19
Abstract: The invention is directed toward porous composites for application to a bone defect site to promote new bone growth. The inventive porous composites comprise a biocompatible polymer and a plurality of particles of bone-derived material, inorganic material, bone substitute material or composite material.  In certain embodiments, the porous composites are prepared using a method that includes a supercritical fluid (e.g., supercritical carbon dioxide) treatment.  The invention also discloses methods of using these composites as bone void fillers.
Patent CA-2638018-A1 (CA)
Inventor: ZIMAN LYNN A
IPC: A61M5/00
Filed: 2007-01-24
Abstract: To ensure that there is no misconnection between a needle, such as for example a spinal or epidural needle, and the appropriate medication, the needle hub the needle is formed, . by molding or extrusion, to have a given configuration. An adapter is placed between the needle and a conventional fluid store, or medical line. The end of the adapter that connects to the needle assembly is formed to have a configuration that is complementary to that of the hub of the needle assembly, so that the adapter and the needle hub may be readily mated to each other. The other end of the adapter is formed to have another configuration, for example a conventional luer, that is readily connectable to a conventional fluid store, such as a syringe that has a conventional luer. The adapter is formed by inter-fitting two elements to effect an integral locking mechanism to prevent the uncoupling of the fluid store and the adapter, once they are securely coupled. By thus configuring the hub of the needle to have a given configuration that is matable only to the end of an adapter that has a complementary configuration, and further providing an adapter that prevents the removal of the fluid store connected thereto, the potential for mis- connecting the needle to a fluid store that contains a different medicament is greatly reduced, if not totally eliminated.
Patent CA-2638401-A1 (CA)
Title: Combined container-syringe
Inventor: KAKIUCHI MAKOTO
IPC: A61M5/32
Filed: 2008-07-31
Abstract: The present invention relates to a combined container-syringe including: a cylindrical cylinder filled with a drug solution; a cylindrical tip provided at the cylinder;  an injection needle mounted on the cylindrical tip; a finger grip provided on the cylinder;  a cylindrical-shaped safety device that is mounted in a slidable manner on the outer periphery of the cylinder and covers the injection needle when it has moved in the front end direction; a retaining member that selectively engages the safety device at a first position that is away from the injection needle and a second position that covers the injection needle; and a coil spring that biases the safety device in the direction of the second position. According to the present invention, it is possible to reliably cover the injection needle by causing the safety device to move with respect to the syringe body and so possible to ensure safety.
Patent CA-2639639-A1 (CA)
Title: Composite structure for protective garment
Inventor: GRILLIOT MARY I
IPC: A62B17/00
Filed: 2008-09-17
Abstract: A protective garment (10) for a firefighter or other emergency worker includes an outer shell (20), at least one of a moisture barrier layer or a thermal insulative layer (22 or 24) and a liner (26) that includes 85%  to 95% by weight hydrophobic fibers and 15% to 10% by weight hydrophilic fibers.